Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Raben

Showing results (141-150 of 161) with videos related to

Pageof 17
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 12, 2016
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129Canhua Xiao, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008Paul Okunieff, Lisa A Kachnic, Louis S Constine, et al.
Cancer|July 16, 2016
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)Vasu Divi, Jonathan Harris, Paul M Harari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2019
Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation CombinationShelby Lennon, Ayman Oweida, Dallin Milner, et al.
Cancer|March 27, 2019
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trialsCarole Fakhry, Qiang Zhang, Maura L Gillison, et al.
Cancer|April 25, 2019
National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancerThomas J George, Aaron J Franke, A Bapsi Chakravarthy, et al.
Cancer|December 2, 2016
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning MeetingJulie E Bauman, Ezra Cohen, Robert L Ferris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2017
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal CancerCarole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
JAMA Oncology|December 23, 2016
The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical TrialJoanne B Weidhaas, Jonathan Harris, Dörthe Schaue, et al.
The Lancet. Oncology|March 4, 2016
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort studyBrian O'Sullivan, Shao Hui Huang, Jie Su, et al.
Pageof 17

Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
International Journal of Radiation Oncology, Biology, Physics|October 12, 2016
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129Canhua Xiao, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008Paul Okunieff, Lisa A Kachnic, Louis S Constine, et al.
Cancer|July 16, 2016
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)Vasu Divi, Jonathan Harris, Paul M Harari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2019
Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation CombinationShelby Lennon, Ayman Oweida, Dallin Milner, et al.
Cancer|March 27, 2019
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trialsCarole Fakhry, Qiang Zhang, Maura L Gillison, et al.
Cancer|April 25, 2019
National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancerThomas J George, Aaron J Franke, A Bapsi Chakravarthy, et al.
Cancer|December 2, 2016
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning MeetingJulie E Bauman, Ezra Cohen, Robert L Ferris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2017
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal CancerCarole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
JAMA Oncology|December 23, 2016
The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical TrialJoanne B Weidhaas, Jonathan Harris, Dörthe Schaue, et al.
The Lancet. Oncology|March 4, 2016
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort studyBrian O'Sullivan, Shao Hui Huang, Jie Su, et al.
Pageof 17